Roughly 1 billion people worldwide have obstructive sleep apnea, making it one of the most common chronic conditions on the planet. Despite those numbers, an estimated 80% of cases remain undiagnosed, meaning hundreds of millions of people are living with disrupted breathing during sleep and have no idea.
Global and U.S. Numbers
That nearly 1 billion global figure covers obstructive sleep apnea specifically, the type where soft tissue in the throat relaxes and physically blocks the airway during sleep. It’s by far the most common form. Central sleep apnea, where the brain temporarily stops sending signals to the muscles that control breathing, is much rarer. In adults over 40, central sleep apnea affects less than 1% of the general population, though it’s more common among people with heart failure.
In the United States, the burden is enormous and growing. A 2025 modeling study published in The Lancet Respiratory Medicine projected a significant rise in obstructive sleep apnea cases over the next three decades, driven by an aging population and rising obesity rates. The researchers built a simulation model using data from the Wisconsin Sleep Cohort and national health surveys, and the trajectory points steadily upward through 2050.
Who Gets Sleep Apnea
Sleep apnea does not affect everyone equally. Men are diagnosed at significantly higher rates than women, though that gap narrows after menopause as hormonal changes reduce the protective effect that estrogen and progesterone have on airway muscle tone. Age is another major factor: prevalence climbs steadily from middle age onward as tissues in the throat lose firmness and the airway becomes easier to obstruct.
Body weight is the single strongest modifiable risk factor. A large meta-analysis pooling data from over 12,800 adults across four community-based cohorts found that 74.3% of people with obesity (a BMI of 30 or higher) had at least mild obstructive sleep apnea. Among people who were overweight but not obese, the rate was still 59.8%. That doesn’t mean sleep apnea is limited to people carrying extra weight. Jaw structure, neck circumference, nasal anatomy, and genetics all play roles, and plenty of lean individuals have significant sleep apnea. But the connection to weight is strong enough that even modest weight loss can reduce the severity of symptoms.
Children Are Affected Too
Sleep apnea isn’t just an adult condition. Between 1% and 5% of children have obstructive sleep apnea across all age groups, from infants through teenagers. In kids, the most common cause is enlarged tonsils and adenoids rather than excess weight. The signs look different than in adults: instead of loud snoring and daytime sleepiness, children with sleep apnea often show behavioral problems, difficulty concentrating in school, bedwetting, or restless sleep with unusual positions like sleeping with the neck hyperextended. Because parents and pediatricians don’t always connect these symptoms to a breathing problem during sleep, pediatric cases are frequently missed.
Why 80% Go Undiagnosed
The University of Utah Health estimates that 80% of sleep apnea cases are never diagnosed. That’s a staggering gap for a condition with real health consequences. Several things drive it. Many people don’t realize they stop breathing at night because they’re asleep when it happens. A bed partner might notice the gasping or choking, but people who sleep alone often have no clue. Snoring is so common that it gets dismissed as a nuisance rather than a potential symptom. And daytime tiredness, the hallmark complaint, gets chalked up to stress, busy schedules, or poor sleep habits rather than a medical condition.
There’s also a diagnostic bottleneck. Traditional sleep studies require spending a night in a sleep lab, which involves waitlists, insurance hurdles, and the simple inconvenience of sleeping in an unfamiliar setting hooked up to sensors. Home sleep tests have made diagnosis more accessible in recent years, but awareness remains the bigger barrier. If you don’t suspect you have sleep apnea, you’ll never take the test.
The Cost of Not Knowing
Undiagnosed sleep apnea isn’t just a quality-of-life issue. The American Academy of Sleep Medicine estimated that undiagnosed obstructive sleep apnea cost the United States approximately $149.6 billion in a single year. That figure includes direct healthcare spending from conditions that untreated sleep apnea worsens (high blood pressure, heart disease, type 2 diabetes, stroke) as well as indirect costs like workplace accidents, lost productivity, and motor vehicle crashes caused by daytime drowsiness.
Each time breathing stops during sleep, oxygen levels drop and the body triggers a stress response. This happens dozens or even hundreds of times per night in severe cases. Over months and years, that repeated stress damages blood vessels, raises blood pressure, disrupts blood sugar regulation, and increases inflammation throughout the body. The downstream effects touch nearly every organ system, which is why untreated sleep apnea shows up in healthcare costs far beyond the sleep clinic.
Mild, Moderate, and Severe Cases
Sleep apnea severity is measured by how many times per hour your breathing stops or becomes dangerously shallow during sleep. Fewer than 5 events per hour is considered normal. Five to 14 events per hour is mild, 15 to 29 is moderate, and 30 or more is severe. The large meta-analysis of community cohorts used that 5-event threshold as the cutoff for any sleep apnea, which is why the prevalence numbers are so high. Many people with mild sleep apnea have few or no noticeable symptoms and may never need treatment beyond positional changes or weight management.
Moderate and severe cases are where the health risks escalate and where treatment with a CPAP machine (which delivers gentle air pressure to keep the airway open) or other interventions makes the biggest difference. The challenge is that severity doesn’t always match how someone feels. Some people with mild sleep apnea are profoundly tired during the day, while others with severe cases have adapted to fragmented sleep and don’t recognize how impaired they’ve become until after treatment starts.